HCV Post-Exposure Prophylaxis for Health Care Workers
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Hepatitis, Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/22/2018 |
| Start Date: | March 15, 2019 |
| End Date: | July 1, 2022 |
| Contact: | Raymond Chung, MD |
| Email: | RChung@partners.org |
| Phone: | 6177247562 |
Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers
This is an unblinded, observational trial of sofosbuvir-velpatasvir in adult health care
workers who are exposed to hepatitis C virus from needlestick injury with hollow-bore
needles.
workers who are exposed to hepatitis C virus from needlestick injury with hollow-bore
needles.
The goal of this study is to assess the safety and tolerability of the use of
sofosbuvir-velpatasvir in the setting of post-exposure prophylaxis among Health Care Workers
exposed to HCV from needlestick injury with hollow-bore needles
sofosbuvir-velpatasvir in the setting of post-exposure prophylaxis among Health Care Workers
exposed to HCV from needlestick injury with hollow-bore needles
Inclusion Criteria:
- Healthcare worker with exposure through needlestick injury with hollow-bore needles to
source patients who are HCV positive
- Healthcare worker must be HCV Ab-
Exclusion Criteria:
- HCV Ab positive
- HCV Ab negative and HCV RNA greater than 1000 IU/ml
- Active malignancy
- Positive urine pregnancy test
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Raymond T Chung, MD
Phone: 617-724-3836
Click here to add this to my saved trials
